Blog
85 Articles
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Report Highlights Potential of TCR Therapy
Dr. Elizabeth Jaffee explains the unique technique used with success for one patient in a new immunotherapy clinical trial.
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
Cherishing the Simple Things
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
New Trial to Find Biomarkers to Guide Treatment
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
Family, Friends, Hope, Strength, and Prayer
Susan Wells had chemotherapy but her treatment took a detour into more chemo and a clinical trial before she had a Whipple procedure.
The Butterfly Effect and Living Every Day to My Fullest
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
An Update on Vitamin C and Cancer
Dr. Lewis Cantley discusses the latest research on and clinical trials of vitamin C for KRAS-mutated and pancreatic cancer.
Targeting the Undruggable KRAS Protein
Dr. Shubham Pant is focusing his research on effective treatments for the KRAS mutation, found in 90% of pancreatic cancers.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
A Clinical Trial Saved My Life
Bob Minetti and his doctors believe that a clinical trial saved his life after a pancreatic cancer diagnosis.